Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism
Open Access
- 26 October 2010
- Vol. 66 (1), 75-81
- https://doi.org/10.1136/thx.2010.150656
Abstract
Background In haemodynamically stable patients with acute symptomatic pulmonary embolism (PE), studies have not evaluated the usefulness of combining the measurement of cardiac troponin, transthoracic echocardiogram (TTE), and lower extremity complete compression ultrasound (CCUS) testing for predicting the risk of PE-related death. Methods The study assessed the ability of three diagnostic tests (cardiac troponin I (cTnI), echocardiogram, and CCUS) to prognosticate the primary outcome of PE-related mortality during 30 days of follow-up after a diagnosis of PE by objective testing. Results Of 591 normotensive patients diagnosed with PE, the primary outcome occurred in 37 patients (6.3%; 95% CI 4.3% to 8.2%). Patients with right ventricular dysfunction (RVD) by TTE and concomitant deep vein thrombosis (DVT) by CCUS had a PE-related mortality of 19.6%, compared with 17.1% of patients with elevated cTnI and concomitant DVT and 15.2% of patients with elevated cTnI and RVD. The use of any two-test strategy had a higher specificity and positive predictive value compared with the use of any test by itself. A combined three-test strategy did not further improve prognostication. For a subgroup analysis of high-risk patients, according to the pulmonary embolism severity index (classes IV and V), positive predictive values of the two-test strategies for PE-related mortality were 25.0%, 24.4% and 20.7%, respectively. Conclusions In haemodynamically stable patients with acute symptomatic PE, a combination of echocardiography (or troponin testing) and CCUS improved prognostication compared with the use of any test by itself for the identification of those at high risk of PE-related death.Keywords
This publication has 24 references indexed in Scilit:
- Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-upJournal of Thrombosis and Haemostasis, 2009
- Guidelines on the diagnosis and management of acute pulmonary embolismEuropean Heart Journal, 2008
- Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic reviewEuropean Heart Journal, 2008
- N-Terminal Pro–Brain Natriuretic Peptide or Troponin Testing Followed by Echocardiography for Risk Stratification of Acute Pulmonary EmbolismCirculation, 2005
- Prognostic Significance of Troponin Elevation and Right Ventricular Enlargement in Acute Pulmonary EmbolismThe American Journal of Cardiology, 2005
- Biomarker-based risk assessment model in acute pulmonary embolismEuropean Heart Journal, 2005
- Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood, 2002
- Association Between Thrombolytic Treatment and the Prognosis of Hemodynamically Stable Patients With Major Pulmonary EmbolismCirculation, 1997
- Distinguishing between acute and subacute massive pulmonary embolism by conventional and Doppler echocardiography.Heart, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958